Drug companies are giving groups of MPs and peers that campaign on health issues hundreds of thousands of pounds a year in “hidden” funding that could hand them “undue influence”, research has found.
The pharmaceutical industry has built up a “hidden web of policy influence” over dozens of all-party parliamentary groups (APPGs) at Westminster by making hundreds of “non-transparent” payments to them, as part of the industry’s wider effort to lobby those in power, researchers claim.
16 health-related APPGs received 168 payments from 35 drug firms worth £1.2m in 2012-18 – one-sixth of their total funding
Two APPGs, on health and cancer, accepted more than £600,000 in that time
50 health-focused APPGs received almost another £1m in 304 payments from patient organisations or health charities, which themselves take sums of money from big pharma